Introduction
The transport of proteins at the surface of mammalian cells is a process of immense biological significance and is preceded by specific protein-receptor interactions (1. 2). It is important to enhance cellular penetration of macromolecules that are not ordinarily transported to a significant extent or of restoring normal transport when a receptor-mediated mechanism is detective (3.4). The intracellular processing of endocytosed macromolecules involves several biochemical events. for example. proteins may be partially degraded in prelysosomal vesicles (5) . may undergo conformational changes (6) . dissociate from their receptors (7) . in acidic endosomes (8) . and may be hydrolyzed to amino acid components in lysosomes (9) . Another general feature of reaction in the degradation of proteins involves reductive cleavage of the disulfide bonds.
Amethopterin (Methotrexate. MTX) is used clinically in the treatment of human leukemias. sarcomas. and other forms of neoplastic diseases (10) . MTX is a potent inhibitor of dihydrofolate reductase from a variety of sources (II). Although the affinity of the enzymes for the inhibitor is quite high. the interaction is noncovalent and pH-dependent (12) . However. resistance toward MTX has been encountered in the clinic and has been attributed in some instances to increased levels of dihydrofolate reductase or to decreased membrane transport of this drug (13). Therefore. it is anticipitated that the latter form of resistance may be partially overcome by § (14) . Furthermore. the introduction of appropriate spacers between MTX and poly(D-lysine) led to conjugates with c"Ytotoxic etlects. These spacers included a small peptide digestible by lysosomal proteases (15) . an acid-sensitive linkage that hydrolyzed spontaneously at the acid pH of endosomes-Iysosomes (16) . and indirect conjugates using a triglycine spacer or a disulfide spacer (17) . It was concluded that the reductive process from the disulfide spacer occurs inside the cells and not at the cell surface. does not require acid pH or lysosomal enzymes and is not mediated by a glutathione-disulfide exchange reaction. In the present work. a conjugate has been prepared in which MTX is linked to poly(O-lysine) through an ethylenediamine (NH: >CHcCHcNH2) spacer as a probe to study the effect of pH-sensitivity of the resultant conjugate. 
Preparation of MTX-EDA
To a solution containing 25 mg of MTX and S mg of etr.ylenediamine in 2 ml of H~O pH 7, 25 mg of EDC was added. After 2 h, the reaction mixture was diluted to 3 ml by HeO, cooled in ice and adjusted hy IN HCI to pH 4.5. The precipitate was collected hy centrifugation and redissolved in 2 ml H 10 by slowly adding IN NaOH dropwise. The acid precipitation was repeated once and the final product of MTX-EDA as a yellow amorphous solid was dissolved in I ml of H~O 
Preparation of MTX-EDA-Afji-Gel 701 COf?jugate
A 1.8 ml aliquot of Affi-Gel 701 (fJmoles of amino group/ m\' head size 1-3 fJ) was centrifuged. The gel pellet was washed twice with 5 ml H,O and resuspended in O.S ml HeO. MTX-EDA solution (0.13 ml of 7.5 mM) was added to the gel suspension. and then 20 mg of EDC was added to the mixture while stirring. After 2 h, the reaction mixture was diluted to 5 ml with H 2 0 and centrifuged. The amount of MTX-EDA conjugate to heads. which was estimated by the difference of unbound MTX-EDA in the supernatant before and after the 2 h reaction was 33% of the total MTX-EDA. The gel pellet was washed extensively with phosphate huffer saline until the supernatant contained no detectable MTX-EDA. The conjugate vvas stored at 4't in phosphate bulTer 61 saline, pH 7.
Preparation of MTX-EDA-Poly(D-Lysine) conjugate
A O.5-ml aliquot of MTX-EDA solution (20 mg/ m]) was added to an equal volume of poly(Dlysine) (40 mg/ml). After thorough mixing. 20 mg of EDC was added and the mixture was incubated in the dark for 17 h at 25°C with occasional shaking. The conjugate was then separated from the free MTX-EDA and other small molecules by Sephadex G-50 gel filtration column (1.5 X 40 cm) equilibrated with phosphate buffer saline. The methotrexate content of the various fractions was assayed by measuring their absorbance at 257 nm in 0.1 M NaOH (18). The conjugate which emerged from the column with the exclusion volume as a sharp symmetrical peak was collected and had an average of 5.S mol of MTX/each mol of poly(D-lysine).
Results and Discussion
The synthesis of a fluorescein conjugate of MTX (MTX-F) has been reported previously in which Iluorescein-diaminopentane was linked to the aand/or y-carboxyl group (s) of MTX lIsing a carhodiimide coupling procedure (l 9). An important consequence of carbodiimide coupling during the synthesis of MTX-F is the possihle generation of the a-carboxyl conjugate and also racemization of the glutamate moiety. During the synthesis of a-and y-glutamate peptides of MTX. Rosowsky and Yu ohserved that the a-substituted isomer was the major product in direct condensation reactions using peptide bond forming reagents such as N.N' -dicydohexyl carbodiimide (20) .
Derivatization of MTX with EDA was accomplished via one of the terminal carboxyl groups. since this region of the molecule is minimally involved in binding to dihydrofolate reductases. Acid precipitation afforded the desired product as a yellow amorphous solid which was confirmed by 'H NMR spectrum and analytical data. It is presumed that the ethylenediamine spacer group is linked covalently to the a-and/ or y-carhoxyl group (s) of MTX. Aliquots of MTX-EDA MTX-EDA-Affi-Gel 701 and MTX-EDA-poly (D-Iysine) derivatives were suspended in citrate-phosphate buffer at pH 4. 5.6 and 7 (21). These gel suspensions were then incuhated at 37t. centrifuged at various time intervals. and the release of MTX was monitored by the absorhance at 257 nm in n.l M NaOH . No release of free MTX was ohserved from these conjugates under these conditions indicating a stable covalent bond between MTX and ethylenediamine spacer. Therefore_ it is concluded that ethylenediamine spacer is prone to be stable under physiological conditions, although it might release MTX once it penetrates inside the cells by some other mechanism. Further studies are needed to confirm this aspect.
